Menu
GWAS Study

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

Escala-Garcia M, Canisius S, Keeman R et al.

34611289 PubMed ID
GWAS Study Type
1355 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

EM
Escala-Garcia M
CS
Canisius S
KR
Keeman R
BJ
Beesley J
AH
Anton-Culver H
AV
Arndt V
AA
Augustinsson A
BH
Becher H
BM
Beckmann MW
BS
Behrens S
BM
Bermisheva M
BS
Bojesen SE
BM
Bolla MK
BH
Brenner H
CF
Canzian F
CJ
Castelao JE
CJ
Chang-Claude J
CS
Chanock SJ
CF
Couch FJ
CK
Czene K
DM
Daly MB
DJ
Dennis J
DP
Devilee P
DT
Dörk T
DA
Dunning AM
ED
Easton DF
EA
Ekici AB
EA
Eliassen AH
FP
Fasching PA
FH
Flyger H
GM
Gago-Dominguez M
GM
García-Closas M
GJ
García-Sáenz JA
GJ
Geisler J
GG
Giles GG
GM
Grip M
GM
Gündert M
HE
Hahnen E
HC
Haiman CA
HN
Håkansson N
HP
Hall P
HU
Hamann U
HJ
Hartikainen JM
HB
Heemskerk-Gerritsen BAM
HA
Hollestelle A
HR
Hoppe R
HJ
Hopper JL
HD
Hunter DJ
JW
Jacot W
JA
Jakubowska A
JE
John EM
JA
Jung AY
KR
Kaaks R
KE
Khusnutdinova E
KL
Koppert LB
KP
Kraft P
KV
Kristensen VN
KA
Kurian AW
LD
Lambrechts D
LM
Le Marchand L
LA
Lindblom A
LR
Luben RN
LJ
Lubiński J
MA
Mannermaa A
MM
Manoochehri M
MS
Margolin S
MD
Mavroudis D
MT
Muranen TA
NH
Nevanlinna H
OA
Olshan AF
OH
Olsson H
PT
Park-Simon TW
PA
Patel AV
PP
Peterlongo P
PP
Pharoah PDP
PK
Punie K
RP
Radice P
RG
Rennert G
RH
Rennert HS
RA
Romero A
RR
Roylance R
RT
Rüdiger T
RM
Ruebner M
SE
Saloustros E
SE
Sawyer EJ
SR
Schmutzler RK
SM
Schoemaker MJ
SC
Scott C
SM
Southey MC
SH
Surowy H
SA
Swerdlow AJ
TR
Tamimi RM
TL
Teras LR
TE
Thomas E
TI
Tomlinson I
TM
Troester MA
VC
Vachon CM
WQ
Wang Q
WR
Winqvist R
WA
Wolk A
ZA
Ziogas A
MK
Michailidou K
CG
Chenevix-Trench G
BT
Bachelot T
SM
Schmidt MK
Chapter II

Abstract

Summary of the research findings

Breast cancer metastasis accounts for most of the deaths from breast cancer. Identification of germline variants associated with survival in aggressive types of breast cancer may inform understanding of breast cancer progression and assist treatment. In this analysis, we studied the associations between germline variants and breast cancer survival for patients with distant metastases at primary breast cancer diagnosis. We used data from the Breast Cancer Association Consortium (BCAC) including 1062 women of European ancestry with metastatic breast cancer, 606 of whom died of breast cancer. We identified two germline variants on chromosome 1, rs138569520 and rs146023652, significantly associated with breast cancer-specific survival (P = 3.19 × 10-8 and 4.42 × 10-8). In silico analysis suggested a potential regulatory effect of the variants on the nearby target genes SDE2 and H3F3A. However, the variants showed no evidence of association in a smaller replication dataset. The validation dataset was obtained from the SNPs to Risk of Metastasis (StoRM) study and included 293 patients with metastatic primary breast cancer at diagnosis. Ultimately, larger replication studies are needed to confirm the identified associations.

1,062 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1355
Total Participants
GWAS
Study Type
Yes
Replicated
293 European ancestry individuals
Replication Participants
European
Ancestry
Russian Federation, Republic of Ireland, Spain, Greece, Netherlands, Sweden, U.S., Belgium, Norway, Finland, Denmark, Poland, Italy, Israel, U.K., Australia, France, Germany
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.